In 2024, the global Peripheral Stent Implants Market was valued at more than USD 4.6 billion, and it is projected to witness substantial growth, reaching around USD 9.7 billion by 2037. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% over the forecast period spanning 2025 to 2037. Rising awareness about peripheral artery diseases (PAD), along with increasing healthcare expenditures, is playing a vital role in boosting market growth globally. The growing preference for minimally invasive procedures and the rising geriatric population further support this upward trend in market expansion.
Peripheral Stent Implants Industry Demand
Peripheral stent implants are medical devices used to treat narrowed or blocked peripheral arteries outside the heart, particularly in the legs, kidneys, and neck. These stents help restore proper blood flow and reduce symptoms such as pain and ulcers, and in severe cases, prevent limb amputation.
The market for peripheral stent implants is experiencing increased demand due to several compelling factors. These devices are known for their cost-effectiveness, reducing the need for prolonged hospitalization and repeated interventions. Their ease of administration, especially through minimally invasive endovascular techniques, makes them highly favored among healthcare professionals and patients alike. Additionally, peripheral stents have a long shelf life, making them practical for inventory management in hospitals and surgical centers. The rise in sedentary lifestyles, increasing prevalence of lifestyle-related disorders, and growing awareness campaigns for early screening of vascular diseases are also boosting the market.
Request Sample@ https://www.researchnester.com/sample-request-7591
Peripheral Stent Implants Market: Growth Drivers & Key Restraint
Growth Drivers
• Rising Prevalence of Peripheral Artery Disease (PAD): The increasing number of individuals suffering from PAD—largely due to aging populations, diabetes, and tobacco use—is a primary driver of demand for peripheral stents.
• Technological Advancements in Stent Design: The introduction of drug-eluting stents (DES), biodegradable stents, and stents with enhanced flexibility and durability is fueling market expansion. Advancements in technology are enhancing patient outcomes and minimizing complications.
• Shift Toward Minimally Invasive Procedures: A global trend favoring non-surgical or less invasive techniques has led to higher adoption of endovascular treatments using stents, especially in outpatient and ambulatory care settings.
Restraint
• Risks and Complications Related to Stent Implantation: Despite advancements, concerns over stent thrombosis, restenosis, and long-term vascular complications can hinder adoption. Moreover, regulatory hurdles and product recalls stemming from performance concerns present significant challenges for market participants.
Peripheral Stent Implants Market: Segment Analysis
Segment Analysis by Product Type
Bare Metal Stents (BMS): Known for their structural support, BMS are widely used where long-term drug exposure is not necessary. However, they face competition from advanced alternatives.
Covered Stents: Designed to prevent blood from leaking through vessel walls, these are favored for treating complex lesions or aneurysms. Their adoption is growing in the treatment of vascular injuries resulting from trauma.
Drug-Eluting Stents (DES): The fastest-growing segment, DES are embedded with medication that helps prevent restenosis. Their high efficacy and low re-intervention rates are driving adoption.
Segment Analysis by Artery Type
Iliac Stents: Commonly used to treat blockages in pelvic arteries, these stents benefit from increasing awareness and diagnosis of PAD.
Femoral-popliteal Stents: As the femoral and popliteal arteries are frequently affected by PAD, stents for these vessels remain in high demand.
Renal and Related Stents: Growth in this segment is linked to rising cases of hypertension and chronic kidney disease where renal artery stenosis plays a role.
Carotid Stents: Utilized for preventing strokes, carotid artery stenting is gaining ground as an alternative to surgical endarterectomy.
Segment Analysis by End‑User
Hospitals: Dominating the segment due to comprehensive vascular surgery units and access to trained specialists.
Ambulatory Surgical Centers (ASCs): Gaining popularity for providing cost-effective and efficient outpatient care, especially for minimally invasive procedures.
Others: Includes specialty clinics and research institutions contributing to niche applications and clinical trials.
Peripheral Stent Implants Market: Regional Insights
North America:
North America is expected to retain a dominant share, driven by high disease awareness, strong reimbursement structures, and early adoption of innovative technologies. The U.S., in particular, has a mature market landscape with advanced healthcare infrastructure supporting broad access to vascular interventions.
Europe:
Europe’s growth is propelled by rising aging population, government initiatives to combat cardiovascular diseases, and collaborations between public and private healthcare sectors. Western European countries such as Germany, France, and the UK are front-runners in the regional market due to well-established healthcare systems.
Asia-Pacific (APAC):
The APAC region is witnessing rapid growth owing to improving healthcare facilities, increasing healthcare expenditure, and a large patient pool. Emerging economies such as China and India are investing heavily in vascular health infrastructure, while urbanization and lifestyle changes contribute to the rising disease burden. Furthermore, market growth is being fueled by advancements in local manufacturing and ongoing innovation.
Top Players in the Peripheral Stent Implants Market
Leading companies driving the Peripheral Stent Implants Market include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Biotronik, Cook Medical, Cardinal Health, MicroPort NeuroTech, iVascular SLU, Royal Philips, and Imperative Care. These companies are continuously innovating in stent technology, enhancing distribution networks, and engaging in strategic collaborations and acquisitions to maintain a competitive edge in the global marketplace.
Access Detailed Report@ https://www.researchnester.com/reports/peripheral-stent-implants-market/7591
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
- rohitgunjal's blog
- Log in or register to post comments